GSK drug suggests potential as COPD treatment
Details of the study, published in the New England Journal of Medicine, showed that patients with COPD who took Advair Diskus 500/50 (fluticasone propionate and salmeterol inhalation powder)
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.